Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...
Thermo Fisher Scientific Inc. ( NYSE: TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...
Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call.
Samples contain all five nucleobases of DNA and RNA, supporting theory that asteroids may have seeded Earth with life's ...